Aclaris therapeutics to participate in two june healthcare conferences

Wayne, pa., may 28, 2025 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the company will participate in two upcoming healthcare conferences in june.

ACRS Ratings Summary

ACRS Quant Ranking